Revna Biosciences and AstraZeneca Transform Lung Cancer Care in Ghana with Precision Therapy Rollout

The strategic partnership between AstraZeneca and Revna Biosciences is rapidly transforming the landscape of lung cancer care in Ghana. Since the initial...

July 31, 2025 | Thursday | News
VedTechBio Advances AI Drug Discovery with RxAgentAI™, Joins Forces with AlphaMeld to Accelerate Therapeutic Development

VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI™ platform cutting drug di...

July 31, 2025 | Thursday | News
Ofichem Acquires Meribel’s Uppsala Site to Boost Early-Stage API Capabilities and Nordic Presence

Ofichem, a European CDMO specialising in high-quality active pharmaceutical ingredients (APIs) and integrated drug development and manufacturing services...

July 30, 2025 | Wednesday | News
Zevra Therapeutics Submits MAA to EMA for Arimoclomol (MIPLYFFA®) in Niemann-Pick Disease Type C

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare ...

July 29, 2025 | Tuesday | News
Can-Fite’s Piclidenoson Shows Promise in Preclinical Vascular Dementia Study Led by UCLA Researchers

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule dr...

July 29, 2025 | Tuesday | News
CORXEL Submits NDA for LENZ Therapeutics’ LNZ100 in China, Marking First Global Regulatory Filing for Aceclidine-Based Eye Drop for Presbyopia

LENZ Therapeutics, Inc. a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidin...

July 29, 2025 | Tuesday | News
Sanofi Secures EU Approval for Sarclisa + VRd in Transplant-Eligible Newly Diagnosed Multiple Myeloma

Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment significantly improved MRD negativity benefit and pro...

July 28, 2025 | Monday | News
Matchpoint Therapeutics Secures Major Partnership with Novartis for Precision Covalent Inhibitor Development

Matchpoint to receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option ex...

July 25, 2025 | Friday | News
Sygnature Discovery Doubles High-Throughput Chemistry Capacity with £1M Investment

  Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), today announces the completion of a major enhancemen...

July 24, 2025 | Thursday | News
Everlab Raises US$10 Million to Scale AI-Driven Preventive Health Platform Globally

Everlab, the AI-powered health platform reimagining preventive care, announced a US$10 million (AU$15 million) seed round led by global growth equity fir...

July 22, 2025 | Tuesday | News
Gelteq Partners with IDT Australia to Establish Dedicated Manufacturing Facility for Global Gel-Based Therapeutics

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white ...

July 21, 2025 | Monday | News
Johnson & Johnson’s TAR-200 Receives FDA Priority Review for BCG-Unresponsive Bladder Cancer

New Drug Application supported by results from the Phase 2b SunRISe-1 study Johnson & Johnson announced that the U.S. Food and Drug Administration (...

July 18, 2025 | Friday | News
Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield to Expand U.S. Drug Production Capabilities

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additiona...

July 17, 2025 | Thursday | News
Qosina Expands Distribution Partnership with Saint-Gobain, Adding 38 New Tubing SKUs to Support Bioprocessing Needs

Qosina, a leading global supplier of OEM single-use components to the medical and bioprocess industries, is pleased to announce the expansion of its part...

July 17, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close